Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
Thrombosis Research|December 1, 1985
Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pHF De Clerck, B Xhonneux, J P Tollenaere, et al.Thrombosis Research|May 15, 1985
Platelet-mediated vascular permeability in the rat: a predominant role for 5-hydroxytryptamineF De Clerck, L Van Gorp, J Beetens, et al.Experientia|February 15, 1988
The signal transducing system coupled to serotonin-S2 receptorsD de Chaffoy de Courcelles, J E Leysen, F de ClerckAgents and Actions|December 1, 1978
Oxatomide protects Trichinella spiralis infected mice from lethal anaphylaxisF De Clerck, L Van Gorp, O Vanparijs, et al.Thrombosis Research|August 1, 1982
Enhanced platelet turnover and prostaglandin production in spontaneously hypertensive ratsF De Clerck, L Van Gorp, B Xhonneux, et al.Cell Biology International Reports|April 1, 1990
Class IV Ca2+ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytesL Ver Donck, G Verellen, R Vandewiele, et al.Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1976
Modification of venous stasis thrombosis in the rat by platelet-active drugs and by heparinF De Clerck, J Goossens, J Vermylen, et al.Journal of Cardiovascular Pharmacology|January 1, 1993
Interplay between platelet-derived 5-hydroxytryptamine and arachidonic acid metabolites limits the thrombolytic efficacy of streptokinase against canine platelet-rich coronary thrombosisG Vandeplassche, C Hermans, L Van Dael, et al.Journal of Cardiovascular Electrophysiology|June 2, 2001
Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit modelH R Lu, P Remeysen, K Somers, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1985
Vernolepin: an antiplatelet compound of natural originG M Laekeman, F De Clerck, A J Vlietinck, et al.Pageof 12